Curecumin(TM) May Be An Effective Treatment For Prostate Cancer

Main Category: Prostate / Prostate Cancer
Also Included In: Biology / Biochemistry;  Men's health;  Cancer / Oncology
Article Date: 20 Mar 2007 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (6 votes)

Healthcare Prof:4 stars

4 (1 votes)


Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its Curecumin(TM) (a Bioresonant Phytotherapeutic(R) form of Turmeric containing curcumin), may be an important treatment for prostate cancer.

"Curcumin, a turmeric root extract, has been shown to possess activity in the treatment and prevention of cancer, multiple sclerosis, and Alzheimer's disease," according to a 3/7/2007 article posted on UroToday.com. "The molecular mechanism for its anticancer effect is largely unknown, although it is thought to inhibit the synthesis of MDM2, an oncoprotein known to bind p53 and modulate p21 expression. In the March 1 issue of Cancer Research, Li and colleagues from the Comprehensive Cancer Center of the University of Alabama report on a study designed to elucidate the molecular anticancer effect of curcumin in a preclinical prostate cancer model." "Curcumin was found to decrease the mRNA and protein expression of the oncoprotein MDM2 and to enhance the expression of tumor modulator p21." "This well-performed study provides an elegant mechanistic explanation for the anticancer effect of curcumin."

It is estimated by the Prostate Cancer Foundation that "prostate cancer currently strikes an estimated one in six Americans. More than 218,000 men in the United States will be diagnosed with prostate cancer this year."

"We are particularly interested in the potential of our Curecumin(TM) product to provide a viable treatment strategy for those with prostate cancer. If proven effective, we may have an efficacious, cost effective, natural treatment for prostate cancer sufferers," said Steven M. Schorr, Chairman & CEO -Bioponic Phytoceuticals, Inc.

Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products for sale in the Complementary Alternative Medicine ("CAM") and natural products markets. The Company has developed several branded product lines in distribution (including the nationally recognized natural nasal spray: Flight Spray). Bioponic is focused on the production of natural products that are used to promote health and well-being. http://www.bioponic.com.

All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control that could cause actual results or events to differ materially from current expectations.

Bioponic Phytoceuticals, Inc.
http://www.bioponic.com

Article adapted by Medical News Today from original press release.
Visit our prostate / prostate cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
James Smith. "Curecumin(TM) May Be An Effective Treatment For Prostate Cancer." Medical News Today. MediLexicon, Intl., 20 Mar. 2007. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/65552.php>

APA
James Smith. (2007, March 20). "Curecumin(TM) May Be An Effective Treatment For Prostate Cancer." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/65552.php.

Please note: If no author information is provided, the source is cited instead.


Prostate / Prostate Cancer

Most Popular Articles



Follow Our Prostate News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Prostate / Prostate Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »